- Home
- DBI vs CMPS Comparison
DBI vs CMPS Comparison
Compare DBI & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBI
- CMPS
- Stock Information
- Founded
- DBI 1991
- CMPS 2020
- Country
- DBI United States
- CMPS United Kingdom
- Employees
- DBI N/A
- CMPS N/A
- Industry
- DBI Clothing/Shoe/Accessory Stores
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- DBI Consumer Discretionary
- CMPS Health Care
- Exchange
- DBI Nasdaq
- CMPS Nasdaq
- Market Cap
- DBI 292.2M
- CMPS 280.2M
- IPO Year
- DBI 1991
- CMPS 2020
- Fundamental
- Price
- DBI $5.44
- CMPS $4.03
- Analyst Decision
- DBI Hold
- CMPS Strong Buy
- Analyst Count
- DBI 2
- CMPS 6
- Target Price
- DBI $5.75
- CMPS $33.60
- AVG Volume (30 Days)
- DBI 2.1M
- CMPS 666.3K
- Earning Date
- DBI 12-10-2024
- CMPS 10-31-2024
- Dividend Yield
- DBI 3.68%
- CMPS N/A
- EPS Growth
- DBI N/A
- CMPS N/A
- EPS
- DBI N/A
- CMPS N/A
- Revenue
- DBI $3,050,038,000.00
- CMPS N/A
- Revenue This Year
- DBI N/A
- CMPS N/A
- Revenue Next Year
- DBI $2.23
- CMPS N/A
- P/E Ratio
- DBI N/A
- CMPS N/A
- Revenue Growth
- DBI N/A
- CMPS N/A
- 52 Week Low
- DBI $4.36
- CMPS $3.86
- 52 Week High
- DBI $11.57
- CMPS $12.75
- Technical
- Relative Strength Index (RSI)
- DBI 47.35
- CMPS 37.75
- Support Level
- DBI $5.18
- CMPS $3.86
- Resistance Level
- DBI $6.21
- CMPS $4.20
- Average True Range (ATR)
- DBI 0.46
- CMPS 0.29
- MACD
- DBI -0.04
- CMPS 0.00
- Stochastic Oscillator
- DBI 42.95
- CMPS 16.59
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment, and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.